Lv4
470 积分 2024-11-06 加入
Rifaximin-treatment for collagenous colitis: A randomised, double-blind, placebo-controlled trial
18天前
已完结
Nitazoxanide versus rifaximin in preventing the recurrence of hepatic encephalopathy: A randomized double‐blind controlled trial
18天前
已完结
Impact of rifaximin on cirrhosis complications and gastric microbiota in patients with gastroesophageal variceal bleeding: A pilot randomized controlled trial
18天前
已完结
Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
18天前
已完结
Efficacies of prokinetics and rifaximin on the positivity to glucose breath test in patients with functional dyspepsia: randomized trial
18天前
已完结
Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points
18天前
已完结
Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrence
18天前
已完结
Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis
18天前
已完结
The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial
18天前
已完结
Rifaximin-treatment for collagenous colitis: A randomised, double-blind, placebo-controlled trial
18天前
已关闭
皖公网安备34019202002308
